Cargando…
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma
BACKGROUND: Hypofractionated stereotactic radiotherapy (HFSRT) is one salvage treatment option in previously irradiated patients with recurrent malignant glioma. We analyzed the results of HFSRT and prognostic factors in a single-institution series. METHODS: Between 1997 and 2003, 19 patients with r...
Autores principales: | Vordermark, Dirk, Kölbl, Oliver, Ruprecht, Klemens, Vince, Giles H, Bratengeier, Klaus, Flentje, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156875/ https://www.ncbi.nlm.nih.gov/pubmed/15924621 http://dx.doi.org/10.1186/1471-2407-5-55 |
Ejemplares similares
-
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)
por: Vordermark, Dirk, et al.
Publicado: (2006) -
Stereotactic body radiation therapy in the re-irradiation situation – a review
por: Mantel, Frederick, et al.
Publicado: (2013) -
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020) -
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results
por: Pouessel, Damien, et al.
Publicado: (2023) -
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)